Integrative functional genomics identifies regulatory mechanisms at coronary artery disease loci

Nature Communications

Volumn 7, Issue , 2016, Pages

  Miller, Clint L ^a   Pjanic, Milos ^a   Wang, Ting ^a   Nguyen, Trieu ^a   Cohain, Ariella ^b   Lee, Jonathan D ^a   Perisic, Ljubica ^c   Hedin, Ulf ^c   Kundu, Ramendra K ^a   Majmudar, Deshna ^a   Kim, Juyong B ^a   Wang, Oliver ^a   Betsholtz, Christer ^c,d   Ruusalepp, Arno ^e,f   Franzén, Oscar ^b,f   Assimes, Themistocles L ^a   Montgomery, Stephen B ^a   Schadt, Eric E ^b   Björkegren, Johan L M ^b,c,g   Quertermous, Thomas ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e TARTU UNIVERSITY HOSPITAL   (Estonia)

^f Clinical Gene Networks AB   (Sweden)

^g UNIVERSITY OF TARTU   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6 RECEPTOR; LMOD1 PROTEIN; PLATELET DERIVED GROWTH FACTOR D; PROCOLLAGEN C PROTEINASE; PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; TCF21 PROTEIN, HUMAN; TRANSCRIPTION FACTOR AP 1;

ALLELE; CARDIOVASCULAR DISEASE; CELLS AND CELL COMPONENTS; COHORT ANALYSIS; ENVIRONMENTAL RISK; GENE EXPRESSION; GENOME; GENOMICS; MORBIDITY; MORTALITY; MUSCLE;

ALLELE; ARTICLE; CHROMATIN; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY MUSCLE; EPIGENETICS; FUNCTIONAL GENOMICS; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; GENETIC VARIABILITY; HUMAN; HUMAN CELL; QUANTITATIVE TRAIT LOCUS; REGULATORY MECHANISM; TRANSCRIPTOMICS; VASCULAR SMOOTH MUSCLE CELL; CHEMISTRY; CORONARY BLOOD VESSEL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMAN GENOME; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PRIMARY CELL CULTURE; PROCEDURES; SMOOTH MUSCLE CELL;

ALLELES; BASE SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CHROMATIN; CORONARY ARTERY DISEASE; CORONARY VESSELS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; MYOCYTES, SMOOTH MUSCLE; PRIMARY CELL CULTURE; QUANTITATIVE TRAIT LOCI; TRANSCRIPTION FACTOR AP-1;

EID: 84978091648     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms12092     Document Type: Article

References (70)

1. McCarthy, M. I. et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat. Rev. Genet. 9, 356-369 (2008)
2. Lander, E. S. & Schork, N. J. Genetic dissection of complex traits. Science 265, 2037-2048 (1994)
3. Deloukas, P. et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat. Genet. 45, 25-33 (2013)
4. Schunkert, H. et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat. Genet. 43, 333-338 (2011)
5. Nikpay, M. et al. A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat. Genet. 47, 1121-1130 (2015)
6. Makinen, V. P. et al. Integrative genomics reveals novel molecular pathways and gene networks for coronary artery disease. PLoS Genet. 10, e1004502 (2014)
7. Ghosh, S. et al. Systems genetics analysis of genome-wide association study reveals novel associations between key biological processes and coronary artery disease. Arterioscler. Thrombo Vasc. Biol. 35, 1712-1722 (2015)
8. Knight, J. C. Approaches for establishing the function of regulatory genetic variants involved in disease. Genome Med. 6, 92 (2014)
9. Musunuru, K. et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 466, 714-719 (2010)
10. Miller, C. L. et al. Disease-related growth factor and embryonic signaling pathways modulate an enhancer of TCF21 expression at the 6q23.2 coronary heart disease locus. PLoS Genet. 9, e1003652 (2013)
11. Visel, A. et al. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 464, 409-412 (2010)
12. Schodel, J. et al. Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression. Nat. Genet. 44, s421-s422 (2012)
13. Smemo, S. et al. Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature 507, 371-375 (2014)
14. Bauer, D. E. et al. An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science 342, 253-257 (2013)
15. GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580-585 (2013)
16. Montgomery, S. B. et al. Transcriptome genetics using second generation sequencing in a Caucasian population. Nature 464, 773-777 (2010)
17. Almlof, J. C. et al. Powerful identification of cis-regulatory SNPs in human primary monocytes using allele-specific gene expression. PLoS ONE 7, e52260 (2012)
18. Maurano, M. T. et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 337, 1190-1195 (2012)
19. Kasowski, M. et al. Variation in transcription factor binding among humans. Science 328, 232-235 (2010)
20. Gaulton, K. J. et al. A map of open chromatin in human pancreatic islets. Nat. Genet. 42, 255-259 (2010)
21. Parker, S. C. et al. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants. Proc. Natl Acad. Sci. USA 110, 17921-17926 (2013)
22. Fairfax, B. P. et al. Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science 343, 1246949 (2014)
23. Bjorkegren, J. L., Kovacic, J. C., Dudley, J. T. & Schadt, E. E. Genome-wide significant loci: how important are they? Systems genetics to understand heritability of coronary artery disease and other common complex disorders. J. Am. Coll. Cardiol. 65, 830-845 (2015)
24. Alexander, M. R. & Owens, G. K. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Ann. Rev. Physiol. 74, 13-40 (2012)
25. Shankman, L. S. et al. KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. Nat. Med. 21, 628-637 (2015)
26. Pai, A. A., Pritchard, J. K. & Gilad, Y. The genetic and mechanistic basis for variation in gene regulation. PLoS Genet. 11, e1004857 (2015)
27. Degner, J. F. et al. DNase I sensitivity QTLs are a major determinant of human expression variation. Nature 482, 390-394 (2012)
28. Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213-1218 (2013)
29. He, H. H. et al. Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics. Genome Res. 22, 1015-1025 (2012)
30. Owens, G. K., Kumar, M. S. & Wamhoff, B. R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84, 767-801 (2004)
31. Spin, J. M., Maegdefessel, L. & Tsao, P. S. Vascular smooth muscle cell phenotypic plasticity: focus on chromatin remodelling. Cardiovasc. Res. 95, 147-155 (2012)
32. Ireland, H. et al. EPCR Ser219Gly: elevated sEPCR, prothrombin F1p2, risk for coronary heart disease, and increased sEPCR shedding in vitro. Atherosclerosis 183, 283-292 (2005)
33. Lopez-Mejias, R. et al. The ZC3HC1 rs11556924 polymorphism is associated with increased carotid intima-media thickness in patients with rheumatoid arthritis. Arthritis Res. Ther. 15, R152 (2013)
34. del Rosario, R. C. et al. Sensitive detection of chromatin-altering polymorphisms reveals autoimmune disease mechanisms. Nat. Methods 12, 458-464 (2015)
35. Sazonova, O. et al. Characterization of TCF21 downstream target regions identifies a transcriptional network linking multiple independent coronary artery disease loci. PLoS Genet. 11, e1005202 (2015)
36. Won, H. H. et al. Disproportionate contributions of select genomic compartments and cell types to genetic risk for coronary artery disease. PLoS Genet. 11, e1005622 (2015)
37. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012)
38. Kundaje, A. et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317-330 (2015)
39. Jostins, L. et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-124 (2012)
40. Franke, A. et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohns disease susceptibility loci. Nat. Genet. 42, 1118-1125 (2010)
41. Samani, N. J. et al. Genomewide association analysis of coronary artery disease. N. Engl. J. Med. 357, 443-453 (2007)
42. Liu, F., Wang, X., Hu, G., Wang, Y. & Zhou, J. The transcription factor TEAD1 represses smooth muscle-specific gene expression by abolishing myocardin function. J. Biol. Chem. 289, 3308-3316 (2014)
43. Coronary Artery Disease (C4D) Genetics Consortium. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat. Genet. 43, 339-344 (2011)
44. Gaidatzis, D., Burger, L., Florescu, M. & Stadler, M. B. Analysis of intronic and exonic reads in RNA-seq data characterizes transcriptional and post-transcriptional regulation. Nat. Biotechnol. 33, 722-729 (2015)
45. Miller, C. L. et al. Coronary heart disease-associated variation in TCF21 disrupts a miR-224 binding site and miRNA-mediated regulation. PLoS Genet. 10, e1004263 (2014)
46. Hagg, S. et al. Multi-organ expression profiling uncovers a gene module in coronary artery disease involving transendothelial migration of leukocytes and LIM domain binding 2: the Stockholm Atherosclerosis Gene Expression (STAGE) study. PLoS Genet. 5, e1000754 (2009)
47. Lu, X. et al. Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease. Nat. Genet. 44, 890-894 (2012)
48. Lu, J., Richardson, J. A. & Olson, E. N. Capsulin: a novel bHLH transcription factor expressed in epicardial progenitors and mesenchyme of visceral organs. Mech. Dev. 73, 23-32 (1998)
49. Hidai, H., Bardales, R., Goodwin, R., Quertermous, T. & Quertermous, E. E. Cloning of capsulin, a basic helix-loop-helix factor expressed in progenitor cells of the pericardium and the coronary arteries. Mech. Dev. 73, 33-43 (1998)
50. Braitsch, C. M., Combs, M. D., Quaggin, S. E. & Yutzey, K. E. Pod1/Tcf21 is regulated by retinoic acid signaling and inhibits differentiation of epicardiumderived cells into smooth muscle in the developing heart. Dev. Biol. 368, 345-357 (2012)
51. Nurnberg, S. T. et al. Coronary artery disease associated transcription factor TCF21 regulates smooth muscle precursor cells that contribute to the fibrous cap. PLoS Genet. 11, e1005155 (2015)
52. Biddie, S. C. et al. Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. Mol. Cell 43, 145-155 (2011)
53. Chen, T. & Dent, S. Y. Chromatin modifiers and remodellers: regulators of cellular differentiation. Nat. Rev. Genet. 15, 93-106 (2014)
54. Farh, K. K. et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518, 337-343 (2015)
55. Corradin, O. et al. Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits. Genome Res. 24, 1-13 (2014)
56. Ross, R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340, 115-126 (1999)
57. Moore, K. J. & Tabas, I. Macrophages in the pathogenesis of atherosclerosis. Cell 145, 341-355 (2011)
58. Feil, S. et al. Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis. Circ. Res. 115, 662-667 (2014)
59. Kojima, Y. et al. Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis. J. Clin. Invest. 124, 1083-1097 (2014)
60. Pechlivanis, S. et al. Risk loci for coronary artery calcification replicated at 9p21 and 6q24 in the Heinz Nixdorf Recall Study. BMC Med. Genet. 14, 23 (2013)
61. Uutela, M. et al. Chromosomal location, exon structure, and vascular expression patterns of the human PDGFC and PDGFD genes. Circulation 103, 2242-2247 (2001)
62. He, C. et al. PDGFRbeta signalling regulates local inflammation and synergizes with hypercholesterolaemia to promote atherosclerosis. Nat. Commun. 6, 7770 (2015)
63. Nanda, V. & Miano, J. M. Leiomodin 1, a new serum response factordependent target gene expressed preferentially in differentiated smooth muscle cells. J. Biol. Chem. 287, 2459-2467 (2012)
64. Hunter, C. A. & Jones, S. A. IL-6 as a keystone cytokine in health and disease. Nat. Immunol. 16, 448-457 (2015)
65. Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) Consortium. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet 379, 1214-1224 (2012)
66. Han, Y., Slivano, O. J., Christie, C. K., Cheng, A. W. & Miano, J. M. CRISPR-Cas9 genome editing of a single regulatory element nearly abolishes target gene expression in mice-brief report. Arterioscler. Thromb. Vasc. Biol. 35, 312-315 (2015)
67. Das, A. et al. Bayesian integration of genetics and epigenetics detects causal regulatory SNPs underlying expression variability. Nat. Commun. 6, 8555 (2015)
68. Braenne, I. et al. Prediction of Causal Candidate Genes in Coronary Artery Disease Loci. Arterioscler. Thromb. Vasc. Biol. 35, 2207-2217 (2015)
69. Trapnell, C. Defining cell types and states with single-cell genomics. Genome Res. 25, 1491-1498 (2015)
70. Landt, S. G. et al. ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res. 22, 1813-1831 (2012)